CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
Código da empresaCBLL
Nome da EmpresaCeriBell Inc
Data de listagemOct 11, 2024
Fundado em2014
CEOMs. Xingjuan (Jane) Chao, Ph.D.
Número de funcionários281
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 11
Endereço360 N. Pastoria Avenue
CidadeSUNNYVALE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94085
Telefone18004360826
Sitehttps://ceribell.com/
Código da empresaCBLL
Data de listagemOct 11, 2024
Fundado em2014
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados